Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men Clinical Trials in Boston, Massachusetts

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy